epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Boostrix
    tetanus/ reduced diphtheria toxoids and acellular pertussis vaccine (Tdap)
  • remove Edex
    alprostadil intracavernous
  • remove Mezofy
    aripiprazole
  • remove Procardia
    nifedipine

multicheck MultiCheck Results - 3 Interactions

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Edex (alprostadil intracavernous) + Mezofy (aripiprazole)

Monitor/Modify Tx


alprostadil intracavernous + aripiprazole oral

monitor BP: combo may increase risk of hypotension, including orthostasis (additive effects)

Smiley face Smiley face Edex (alprostadil intracavernous) + Procardia (nifedipine)

Monitor/Modify Tx


alprostadil intracavernous + nifedipine

monitor BP: combo may increase risk of hypotension (additive effects)

Smiley face Smiley face Mezofy (aripiprazole) + Procardia (nifedipine)

Monitor/Modify Tx


aripiprazole oral + nifedipine

monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

Additional Considerations

Smiley face Smiley face aripiprazole oral in Mezofy

drug interactions apply only to oral aripiprazole forms; see other aripiprazole products for potentially relevant interactions

aripiprazole is a substrate of CYP2D6 and CYP3A4; drug interaction guidance may vary with CYP450 inhibitors if patient is CYP2D6 poor metabolizer (PM)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information